The latest Business updates from the science industry
by Heather Hobbs
Eppendorf AG Appoints Eva van Pelt as New Management Board Member
Since 1st October 2017 Eva van Pelt has taken up Management Board responsibility for the area of Commercial Organisation and thus worldwide responsibility for sales, marketing, and service in the Eppendorf Group. This Management Board mandate was newly created at the end of 2016, and has been under the interim management of Thomas Bachmann, President & CEO, since that time. Van Pelt was appointed to the Management Board in June by the Supervisory Board.
New Eppendorf Management Board Member, Eva van Pelt.
“With Eva van Pelt, we were able to win a Board member with experience in international management. She has extensive expertise in sales, service, business development and product management,” said Philipp von Loeper, Chairman of the Supervisory Board of Eppendorf AG. “Currently we are repositioning the Eppendorf Group to make it fi t for the future - sustainably, profi tably and over the long term. With the addition of Eva van Pelt, the Management Board level of the company is now complete and ready
to successfully implement the changes and developments we have already initiated,” added Bachmann.
Van Pelt noted: “The Eppendorf Group is a very healthy company and a well-known player in the life science industry. I am looking forward to supporting Eppendorf during such an exciting time and tapping new potential together with the leadership team and Eppendorf’s employees.”
Before joining Eppendorf, van Pelt served as Managing Director for the EMEA region of Leica Microsystems at the Danaher Corporation. Prior to that, she headed Healthcare and Life Sciences for the EME region at Hitachi Data Systems. Her previous positions also include directing the Health Services and Global Solutions unit at Siemens Medical Solutions in Den Haag, Netherlands.
44109pr@reply-direct.com
Partnership Will Help Uptake of Specialist Diagnostics
Gilson Officially Opens Its New World Class UK Centre Of Excellence Facility
“This investment reinforces our commitment to science and provides the means necessary to support our continued growth within the UK and Europe,” said Peter Tudor, European Director of Gilson. “Our mission is to partner with the scientifi c community and help researchers advance the pace of discovery. We do this by creating laboratory tools that improve the results of tomorrow and a solid infrastructure through our global Centres of Excellence that enables us to distribute our solutions and provide the best technical support and services possible. Our new, modern facility compliments the recent evolution of our corporate branding, which is aligned to the company’s path and vision to enable verifi able science and making lab life easier for researchers.”
The event was celebrated during a champagne reception attended by Gilson’s key customers, partners and members of the business community.
(l-r) The Grand Opening with Peter Tudor, Gilson’s European Director with Andrew Selous and Chris Wingad, Gilson’s UK Sales Director
Gilson opened its new world-class, purpose built UK Centre of Excellence in Dunstable on 21 September 2017. At an exclusive Grand Opening Ceremony, Andrew Selous, MP for South West Bedfordshire and Peter Tudor, Gilson European Director, offi cially unveiled the new building.
Gilson’s continued growth within the UK and commitment to excellence has fueled their demand and need to relocate to a larger and more modern premises. Formally housed at Charles Street in Luton for over thirty years, this new state of the art facility has been home to Gilson’s UK team of liquid handling experts and customer support since April 2017. Their new UKAS Accredited Pipette Service Centre provides unrivalled support and maintenance for all makes of pipettes, not only Gilson’s prestigious PIPETMAN brand. The building also features new application development laboratories and a larger, more streamline distribution centre, enabling Gilson to provide enhanced technical and customer support.
David Giles, Chairman of Alpha Laboratories Ltd and Nadia Whittley, CEO Arquer
Arquer Diagnostics has appointed Alpha Laboratories as its exclusive distributor in the UK and Republic of Ireland. Sunderland- based Arquer develops breakthrough diagnostic tests for the detection of bladder and prostate cancer. Its non-invasive cancer diagnostic tests are based on the MCM5 (minichromosome
maintenance protein)
platform. The first Arquer product is ADXBLADDER, a bladder cancer diagnostic test and a number of clinical trials are running to validate many other indications.
Michelle Holland, Alpha Laboratories’ Diagnostics Sales and Marketing Director said, “Arquer shares the Alpha Laboratories’ vision to provide innovative diagnostic pathways that enhance patient care and improve outcomes, whilst reducing overall healthcare costs. We welcome this partnership to expand our specialist diagnostics portfolio into this important clinical area.”
“One of the key elements of the success of any product launch is the quality of the technical and scientific support delivered to all stakeholders. I am extremely excited about the partnership with Alpha Laboratories, as they have an incredible track record of success and a reputation in the IVD field. The Arquer Diagnostics’ Team and I look forward to many years of success together
with Inside Gilson’s new state of the art facility
44126pr@reply-direct.com Alpha Laboratories”, said
Nadia Whittley, Arquer CEO.
44119pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44
